Concentrix’s (CNXC) “Outperform” Rating Reiterated at Barrington Research

Barrington Research reiterated their outperform rating on shares of Concentrix (NASDAQ:CNXC) in a research note issued to investors on Tuesday,Benzinga reports. They currently have a $62.00 price objective on the stock.

A number of other brokerages have also recently issued reports on CNXC. Wall Street Zen upgraded Concentrix from a “hold” rating to a “buy” rating in a report on Saturday, February 14th. Weiss Ratings lowered shares of Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a research note on Thursday, January 29th. Finally, Robert W. Baird set a $52.00 price objective on shares of Concentrix in a report on Wednesday, January 14th. Three analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $63.75.

Concentrix Stock Performance

Shares of Concentrix stock opened at $31.92 on Tuesday. The business has a 50-day simple moving average of $35.99 and a 200 day simple moving average of $40.97. Concentrix has a one year low of $29.35 and a one year high of $66.00. The company has a debt-to-equity ratio of 1.67, a current ratio of 1.40 and a quick ratio of 1.40. The firm has a market capitalization of $1.96 billion, a price-to-earnings ratio of -1.53, a PEG ratio of 0.32 and a beta of 0.50.

Concentrix (NASDAQ:CNXC) last announced its quarterly earnings results on Tuesday, January 13th. The company reported $2.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.93 by $0.02. Concentrix had a positive return on equity of 16.91% and a negative net margin of 13.02%.The business had revenue of $2.55 billion for the quarter, compared to analyst estimates of $2.54 billion. During the same quarter in the prior year, the company earned $3.26 earnings per share. The company’s quarterly revenue was up 4.3% on a year-over-year basis. Concentrix has set its Q1 2026 guidance at 2.570-2.690 EPS and its FY 2026 guidance at 11.480-12.070 EPS. On average, research analysts anticipate that Concentrix will post 10.11 earnings per share for the current fiscal year.

Concentrix Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, February 10th. Investors of record on Friday, January 30th were issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a dividend yield of 4.5%. The ex-dividend date of this dividend was Friday, January 30th. Concentrix’s payout ratio is -6.91%.

Insiders Place Their Bets

In related news, CEO Christopher A. Caldwell purchased 1,000 shares of Concentrix stock in a transaction that occurred on Thursday, January 29th. The stock was bought at an average price of $37.07 per share, for a total transaction of $37,070.00. Following the completion of the transaction, the chief executive officer owned 362,075 shares in the company, valued at $13,422,120.25. This represents a 0.28% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 0.90% of the company’s stock.

Institutional Trading of Concentrix

Hedge funds have recently added to or reduced their stakes in the stock. Huntington National Bank grew its position in shares of Concentrix by 6,011.1% during the 3rd quarter. Huntington National Bank now owns 550 shares of the company’s stock valued at $25,000 after acquiring an additional 541 shares during the period. Quent Capital LLC bought a new stake in shares of Concentrix in the 3rd quarter worth approximately $29,000. Larson Financial Group LLC lifted its stake in Concentrix by 224.9% in the third quarter. Larson Financial Group LLC now owns 692 shares of the company’s stock valued at $32,000 after purchasing an additional 479 shares during the last quarter. Geneos Wealth Management Inc. lifted its stake in Concentrix by 532.7% in the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock valued at $34,000 after purchasing an additional 522 shares during the last quarter. Finally, Rothschild Investment LLC grew its holdings in Concentrix by 14,980.0% during the third quarter. Rothschild Investment LLC now owns 754 shares of the company’s stock valued at $35,000 after purchasing an additional 749 shares during the period. Institutional investors own 90.34% of the company’s stock.

Concentrix Company Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.